Natera, Inc., a diagnostics company, provides molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera molecular residual disease test for assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based genomic profiling test, that provides insight into genomic alterations and biomarkers; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product. It serves independent laboratories, national and regional reference laboratories, medical centers and physician practices, research laboratories, and pharmaceutical companies through its direct sales force, and a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

Natera, Inc.

IC Enterra Yenilenebilir Enerji AS ( ($TR:ENTRA) ) has issued an announcement. IC İçtaş İnşaat Sanayi ve Ticaret AŞ has increased its stake in IC E...

IC İçtaş lifts stake in IC Enterra Yenilenebilir Enerji

The latest update is out from MARGUN ENERJI URETIM SANAYI VE TICARET A.S. ( ($TR:MAGEN) ). Borsa Istanbul has completed its periodic review of majo...

Borsa Istanbul Revises Key Indices as Margun Enerji Exits BIST 100

IC Enterra Yenilenebilir Enerji AS ( ($TR:ENTRA) ) has issued an update. IC Enterra Yenilenebilir Enerji A.Ş. operates in the renewable energy sect...

IC Group Unit Raises Stake in IC Enterra Yenilenebilir Enerji

The latest announcement is out from Kaplamin Ambalaj Sanayi ve Ticaret A.S. ( ($TR:KAPLM) ). A disclosure filed via the Turkish Public Disclosure P...

Institutional investors adjust stakes in Kaplamin Ambalaj and peers

IC Enterra Yenilenebilir Enerji AS ( ($TR:ENTRA) ) just unveiled an update. Trading in IC Enterra Yenilenebilir Enerji’s ENTRA.E shares on Borsa Is...

IC Enterra Shares Enter Single-Price Auction After Circuit Breaker on Borsa Istanbul

Bernstein analyst Eve Burstein maintained a Buy rating on Natera today and set a price target of $365.00. Burstein covers the Healthcare sector, fo...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NTRA	$390.79	-0.03%	1.68M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NTRA	$390.79	-0.0%	1.68M
3
4
5
6

NTRA

Get Natera, Inc. Data in Excel

Get Natera, Inc. Data in Excel